Olanzapine for prevention of chemotherapy-induced nausea and vomiting in children and adolescents: a multi-center, feasibility study
ConclusionA pediatric trial of olanzapine for CINV control is feasible. Our findings will inform the design of a future study.
Source: Supportive Care in Cancer - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Cancer in Adolescents | Chemotherapy | Children | Dexamethasone | Pediatrics | Study | Zofran | Zyprexa